VI.2 Elements for a public summary

Share "VI.2 Elements for a public summary"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "VI.2 Elements for a public summary"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 4 páginas )

Texto

Referências

Descarregar agora ( PDF - 4 páginas - 72.89 KB )

Documentos relacionados

Bendamustine is used alone (monotherapy) or in combination with other medicines for the treatment of patients with

Important potential risks Risk What is known Including reason why it is considered a potential risk Damage to the kidneys renal toxicity Patients using bendamustine who get tumour

Documentos relacionados

VI.2 Elements for a Public Summary

,with the World Health Organisation (WHO) estimating that depression affects 350 million people with the burden 50% higher for females than males.

Page 14 of 37 VI.2 Elements for a public summary

PDF VI.2 Elements for a public summary VI.2.1 ... - Lægemiddelstyrelsen

PDF VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology

VI.2 Elements for a Public Summary

Guidance on format of the RMP in the EU in integrated format